4.1 Article

Patterns of symptom development in patients with motor neuron disease

Journal

Publisher

TAYLOR & FRANCIS LTD
DOI: 10.1080/21678421.2017.1386688

Keywords

Motor neuron disease; amyotrophic lateral sclerosis; symptom development; upper motor neuron; lower motor neuron

Funding

  1. ALS Foundation Netherlands
  2. Prinses Beatrix Spierfonds
  3. European Community's Health Seventh Framework Programme [259867]
  4. SOPHIA - EU Joint Programme - Neurodegenerative Disease Research, JPND
  5. Biogen Idec
  6. Netherlands Organization for Health Research and Development (Veni scheme)
  7. MQ
  8. Netherlands Organization for Health Research and Development (Vici scheme)
  9. Baxalta

Ask authors/readers for more resources

Objective: To investigate whether symptom development in motor neuron disease (MND) is a random or organized process. Methods: Six hundred patients with amyotrophic lateral sclerosis (ALS), upper motor neuron (UMN) or lower motor neuron (LMN) phenotypes were invited for a questionnaire concerning symptom development. A binomial test was used to examine distribution of symptoms from site of onset. Development of symptoms over time was evaluated by Kaplan-Meier analysis. Results: There were 470 respondents (ALS = 254; LMN = 100; UMN = 116). Subsequent symptoms were more often in the contralateral limb following unilateral limb onset (ALS: arms p = 1.05 x 10(-8), legs p < 2.86 x 10(-15); LMN phenotype: arms p = 6.74 x 10(-9), legs p = 6.26 x 10(-6); UMN phenotype: legs p = 4.07 x 10(-14)). In patients with limb onset, symptoms occurred significantly faster in the contralateral limb, followed by the other limbs and lastly by the bulbar region. Patterns of non-contiguous symptom development were also reported: leg symptoms followed bulbar onset in 30%, and bulbar symptoms followed leg onset in 11% of ALS patients. Conclusions: Preferred spread of symptoms from one limb to the contralateral limb, and to adjacent sites appears to be a characteristic of MND phenotypes, suggesting that symptom spread is organized, possibly involving axonal connectivity. Non-contiguous symptom development, however, is not uncommon, and may involve other factors.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.1
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available